Skip to menu Skip to content Skip to footer

2024

Conference Publication

Endothelial progenitors: Unlocking Tumor Vessel Normalization to Overcome Therapeutic Challenges in Melanoma

Sormani, L., Hashemi, G., Li, H., Zhou, C., Li, K., Chan, S., Tan, S.X., Nguyen, Q., Roy, E. and Khosrotehrani, K. (2024). Endothelial progenitors: Unlocking Tumor Vessel Normalization to Overcome Therapeutic Challenges in Melanoma. 53rd Annual ESDR Meeting, Lisbon, Portugal, 4-7 September 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.10.391

Endothelial progenitors: Unlocking Tumor Vessel Normalization to Overcome Therapeutic Challenges in Melanoma

2024

Conference Publication

404 Spatial transcriptomic signatures in primary melanomas associated with sentinel node positivity

Muller, N. M., Tan, S. X., Zhou, C., Kao, Y., Stark, M., Nguyen, Q. and Khosrotehrani, K. (2024). 404 Spatial transcriptomic signatures in primary melanomas associated with sentinel node positivity. 53rd Annual ESDR Meeting, 4-7 September 2024, Lisbon, Portugal. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.10.414

404 Spatial transcriptomic signatures in primary melanomas associated with sentinel node positivity

2024

Conference Publication

Systems genetics multi-trait analysis of mouse wound healing reveals novel trait interactions with candidate genes characterised by their epidermal expression niche

Muller, N.M., Tan, S.X., Galbraith, J., Zhou, C., Roy, E. and Khosrotehrani, K. (2024). Systems genetics multi-trait analysis of mouse wound healing reveals novel trait interactions with candidate genes characterised by their epidermal expression niche. 53rd Annual ESDR Meeting, Lisbon, Portugal, 4-7 September 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.10.546

Systems genetics multi-trait analysis of mouse wound healing reveals novel trait interactions with candidate genes characterised by their epidermal expression niche

2024

Conference Publication

Pathologist consensus for diagnostic labels is crucial in the developement of artificial intelligence training data in dermatology

Muller, N.M., Tan, S.X., Rutjes, C., Khosrotehrani, K., von Schuckmann, L., Betz-Stablein, B. and Soyer, H. P. (2024). Pathologist consensus for diagnostic labels is crucial in the developement of artificial intelligence training data in dermatology. 53rd Annual ESDR Meeting, Lisbon, Portugal, 4-7 September 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jid.2024.10.431

Pathologist consensus for diagnostic labels is crucial in the developement of artificial intelligence training data in dermatology

2024

Conference Publication

Skin adverse events of anti-cancer treatments: An examination of drug-adverse events associations

Khosrotehrani, Kiarash, Salah, Samir, Pages, Cecile, Lacouture, Mario E. and Sibaud, Vincent (2024). Skin adverse events of anti-cancer treatments: An examination of drug-adverse events associations. COSA's 51st Annual Scientific Meeting Bridging gaps, building progress, breaking down disparities, Gold Coast, QLD Australia, 13–15 November 2024. Richmond, VIC Australia: John Wiley & Sons.

Skin adverse events of anti-cancer treatments: An examination of drug-adverse events associations

2023

Conference Publication

Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses

Dielenseger, P., Lacouture, M., Khosrotehrani, K., De Barros Silva, G., Wolf, J. Ryan, Kerob, D., Trombetta, M., Atenguena, E.O., Pan, M., Scotte, F., Krakowski, I. and Dreno, B. (2023). Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.873

Dermocosmetics in management of cancer-related skin toxicities: International expert consensus highlighting the key role of oncology nurses

2023

Conference Publication

Dermocosmetics in management of cancer-related skin toxicities: International expert consensus

Dreno, Brigitte, Khosrotehrani, Kiarash, De Barros Silva, Giselle, Ryan-Wolf, Julie, Kerob, Delphine, Trombetta, Mark G., Atenguena Okobalemba, Etienne, Dielenseger, Pascale, Pan, Meng and Lacouture, Mario E. (2023). Dermocosmetics in management of cancer-related skin toxicities: International expert consensus. 2023 ASCO Annual Meeting, Chicago, IL United States, 2-6 June 2023. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2023.41.16_suppl.e24115

Dermocosmetics in management of cancer-related skin toxicities: International expert consensus

2023

Conference Publication

Dermocosmetics in management of cancer-related skin toxicities: International expert consensus

Dreno, Brigitte, Khosrotehrani, Kiarash, Silva, Giselle De Barros, Ryan-Wolf, Julie, Kerob, Delphine, Trombetta, Mark G., Okobalemba, Etienne Atenguena, Dielenseger, Pascale, Pan, Meng and Lacouture, Mario E. (2023). Dermocosmetics in management of cancer-related skin toxicities: International expert consensus. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2023. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.

Dermocosmetics in management of cancer-related skin toxicities: International expert consensus

2023

Conference Publication

275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival

Zhou, C., Tan, S. X., Kao, Y., Claeson, M., Brown, S., Lambie, D., Whiteman, D., Soyer, H., Stark, M., Nguyen, Q. and Khosrotehrani, K. (2023). 275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.279

275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival

2023

Conference Publication

Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trial

Cox, Charlotte, Fry, Kirsty, Sivakumaran, Yogeesan, Spelman, Lynda and Khosrotehrani, Kiarash (2023). Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trial. HOBOKEN: WILEY.

Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trial

2023

Conference Publication

Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort study

Lee, Ruby, Tseng, Anne, Liyanage, Upekha, Brown, Susan and Khosrotehrani, Kiarash (2023). Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort study. HOBOKEN: WILEY.

Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort study

2023

Conference Publication

1439 Development of a complex skin organ in human induced pluripotent stem cell-derived organoids

Shafiee, A., Sun, J., Ahmed, I., Brown, J. and Khosrotehrani, K. (2023). 1439 Development of a complex skin organ in human induced pluripotent stem cell-derived organoids. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1455

1439 Development of a complex skin organ in human induced pluripotent stem cell-derived organoids

2023

Conference Publication

Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients

Cox, Charlotte, Lee, Ruby, Liyanage, Upekha, Brown, Susan, Isbel, Nicole, Chambers, Daniel, Griffin, Anthony, Campbell, Scott, Hopkins, Peter, Schaider, Helmut, Soyer, Peter and Khosrotehrani, Kiarash (2023). Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients. HOBOKEN: WILEY.

Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients

2023

Conference Publication

Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy

Wong, H., Lee, R., Chong, S., Kapadia, S., Murigneux, V., Freeman, M., Soyer, H., Roy, E. and Khosrotehrani, K. (2023). Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 12 - 13 May 2023. Oxford, United Kingdom: Elsevier.

Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy

2023

Conference Publication

PDGFRA-expressing endovascular progenitors contribute to differentiated endothelium of aorta and wounds

Styke, C., Kaur, S., Sim, S., Zhao, J., Shafiee, A., Zhou, C., Wong, H. and Khosrotehrani, K. (2023). PDGFRA-expressing endovascular progenitors contribute to differentiated endothelium of aorta and wounds. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1476

PDGFRA-expressing endovascular progenitors contribute to differentiated endothelium of aorta and wounds

2023

Conference Publication

A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancy

Mahon, Clare and Khosrotehrani, Kiarash (2023). A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancy. HOBOKEN: WILEY.

A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancy

2023

Conference Publication

Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial

Cox, C., Fry, K., Sivakumaran, Y., Spelman, L. and Khosrotehrani, K. (2023). Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial. 1st International Societies for Investigative Dermatology Meeting Abstract Supplement, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1530

Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial

2023

Conference Publication

Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis

Hashemi, G., Le Bourhis, L. Sormani, Dight, J., Zhou, C., Roy, E. and Khosrotehrani, K. (2023). Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10-13 May 2023. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.jid.2023.03.1288

Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis

2023

Conference Publication

The impact of immune checkpoint inhibitors on actinic keratosis

Cox, Charlotte, Brown, Susan, Ladwa, Rahul and Khosrotehrani, Kiarash (2023). The impact of immune checkpoint inhibitors on actinic keratosis. HOBOKEN: WILEY.

The impact of immune checkpoint inhibitors on actinic keratosis

2023

Conference Publication

Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis

Hashemi, G., Sormani Le Bourhis, L., Dight, J., Zhou, C., Roy, E. and Khosrotehrani, K. (2023). Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, May 12-13 2023. Oxford, United Kingdom: Elsevier.

Targeting tumour vascularisation through endothelial-specific Sox9 deletion reduces melanoma metastasis